scispace - formally typeset
Open AccessJournal Article

Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine.

TLDR
Observations provide strong evidence that the reactive intermediate formed in microsomes from acetarninophen and in solution from N-hydroxyacetaminophen is N-acetyl-p-benzoquinoneimine.
Abstract
Adding ascorbic acid to microsomal incubations containing acetaminophen inhibited covalent binding of the reactive metabolite. Adding ascorbic acid to incubations containing acetaminophen and cysteine markedly decreased acetaminophen-cysteine adduct formation. Ascorbic acid addition to aqueous incubations containing N-hydroxyacetaminophen and cysteine similarly inhibited the nonenzymatic formation of an acetaminophen-cysteine adduct. Therefore, the chemical reactions responsible for the nonenzymatic decomposition of N-hydroxyacetaminophen to yield acetaminophen-cysteine adducts were examined. In aqueous solutions above pH 7, N-hydroxyacetaminophen rapidly dehydrated to N-acetyl-p-benzoquinoneimine. In the absence of reducing compounds N-acetyl-p-benzoquinoneimine reacted with another molecule of N-hydroxyacetaminophen to give equal amounts of nitrosophenol and acetaminophen. The addition of cysteine or ascorbic acid slowed the decomposition of N-hydroxyacetaminophen and inhibited the formation of nitrosophenol. Cysteine effected these changes through decreasing the concentration of N-acetyl-p-benzoquinoneimine, primarily by reducing it to acetaminophen at low pH (5.5-7.0) or by conjugating with it to yield an acetaminophen-cysteine adduct at high pH (7.5-11.0). Ascorbic acid produced its effects only through reduction of the N-acetyl-p-benzoquinoneimine intermediate; thus acetaminophen was the only product. These observations provide strong evidence that the reactive intermediate formed in microsomes from acetarninophen and in solution from N-hydroxyacetaminophen is N-acetyl-p-benzoquinoneimine.

read more

Citations
More filters
Journal ArticleDOI

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

TL;DR: It is concluded that N-acetylcysteine treatment should be started within eight hours of an acetaminophen overdose, but that treatment is still indicated at least as late as 24 hours after ingestion, and it may be superior when treatment is delayed.
Journal ArticleDOI

Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches.

TL;DR: An overview is presented on the molecular aspects of toxicity due to paracetamol (acetaminophen) and structural analogues, with emphasis on four main topics, that is, bioactivation, detoxication, chemoprevention, and chemoprotection.
Journal ArticleDOI

Toxic drug effects associated with oxygen metabolism: Redox cycling and lipid peroxidation

TL;DR: Powerful antioxidant systems of the cell maintain low steady state concentrations of oxygen metabolites, and toxic effects may, in part, also be expleined by the constant drain of reducing equivalents resulting from redox cycling.
Journal ArticleDOI

Paracetamol: New Vistas of an Old Drug

TL;DR: These findings finally explain the mechanism of action of paracetamol and the peculiarity of its effects, including the behavioral ones.
Journal ArticleDOI

Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2

TL;DR: The extensive APAP-oxidizing capacity of this hamster P450, designated P450IA2 based upon its similarity to rat P450d and rabbit form 4 in terms of NH2-terminal amino acid sequence, spectral characteristics, immunochemical properties, and inducibility by BNF, agrees with previous reports concerning the APAP substrate specificity of the rat and rabbit P 450IA2 proteins.
Related Papers (5)